Initial reporter phone: (b)(6).Additional information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
Additional information was received on 12-apr-2023.It was discovered post use of biosense webster products.No intervention was reported.Patient required extended hospitalization because of the adverse event.The generator service was not needed.Therefore, processed the following fields: d10.Concomitant medical products and therapy dates.B2.Is hospitalization initial/prolonged.H6.Health effect - impact code.In addition, the physician information was provided.Therefore, processed section e.Initial reporter.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|